Home LiteratureArticle Details
PMID: 15579509 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.

Journal of the American Society of Nephrology : JASN ·Vol. 15 ·No. 12 ·2004-12-00 ·Pages 3063-72

Adamczak M, Gross ML, Amann K, Ritz E

Abstract

There is increasing evidence from both human and experimental studies that at least partial reversal of glomerulosclerosis can be achieved by glomerular remodeling. This requires substantial changes in glomerular architecture, specifically of glomerular capillaries. It was the purpose of the present study to characterize the stereologic and topologic characteristics of glomerular capillaries when partial reversal of glomerular lesions is achieved by high-dose angiotensin-converting enzyme inhibitor treatment. Sham-operated male Sprague-Dawley rats were compared with subtotally nephrectomized (SNX) rats. The latter were kept untreated for 8 wk and subsequently randomly divided into one group that was continued without treatment and another group that was treated with enalapril (48 mg/kg body wt per d administered in the drinking fluid for 4 wk). Renal morphology was evaluated after 8 or 12 wk, respectively, by stereologic techniques after pressure-controlled perfusion fixation. In SNX rats at 8 and particularly at 12 wk, the glomerulosclerosis index was significantly higher than in sham-operated rats. At 12 wk, it was lower in rats that had been treated for 4 wk with enalapril compared with untreated SNX rats, suggesting partial reversal of glomerular lesions. This was associated with a decrease in mean glomerular volume and mean glomerular tuft volume, a reduced number of capillaries per glomerulus, and reduced total length of capillaries per glomerulus but without any significant change in the length of individual capillaries. The numerical capillary density (Euler number density) as an index of topologic complexity did not change. The total capillary surface area per glomerulus was strikingly increased after subtotal nephrectomy and partially reversed after enalapril. This was accounted for primarily by fewer capillaries without any change in diameter. In parallel, the number of endothelial cells per glomerulus was strikingly increased after subtotal nephrectomy and decreased with enalapril treatment, but endothelial cell volume remained elevated. The study shows harmonious coordinate remodeling of the entire glomerulus during regression of glomerular lesions after subtotal nephrectomy. Proportionate reduction of glomerular volume and capillary number without change of individual capillary length were found. The numerical capillary density of the tuft therefore remained unchanged.

MeSH Terms
Angiotensin-Converting Enzyme Inhibitors/pharmacology Animals Capillaries/physiology,ultrastructure Enalapril/pharmacology Endothelial Cells/pathology,ultrastructure Glomerulonephritis/drug therapy,pathology,physiopathology Kidney Glomerulus/blood supply,pathology,ultrastructure Male Microcirculation/drug effects Microscopy, Electron Nephrectomy Rats Rats, Sprague-Dawley Recovery of Function/drug effects,physiology
Chemicals
Angiotensin-Converting Enzyme Inhibitors Enalapril
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Adamczak Marcin
Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Francuska 20/24 Street, 40-027 Katowice, Poland. nefro@spskm.katowice.pl
Gross Marie-Luise
Amann Kerstin
Ritz Eberhard
Article Info
Journal
Journal of the American Society of Nephrology : JASN
Abbr.
J Am Soc Nephrol
ISSN
1046-6673
Published
2004-12-00
Pages
3063-72
Language
English
Region
United States
NLM ID
9013836
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com